Albumin globulin ag ratio
Pro Research Analysisby 
Searched over 200M research papers
Prognostic Value of Albumin-to-Globulin Ratio (AGR) in Various Diseases
Introduction to Albumin-to-Globulin Ratio (AGR)
The albumin-to-globulin ratio (AGR) is a calculated value derived from the levels of albumin and globulin in the blood. It has been increasingly recognized as a significant prognostic marker in various diseases, particularly cancers and inflammatory conditions. This article synthesizes findings from multiple studies to highlight the prognostic value of AGR in different medical contexts.
AGR in Cancer Prognosis
General Cancer Prognosis
Several meta-analyses have demonstrated that a low pretreatment AGR is associated with poor overall survival (OS), disease-free survival (DFS), and progression-free survival (PFS) across various cancers. For instance, a comprehensive meta-analysis involving 15,356 cancer patients found that low AGR was significantly linked to poor OS (HR=2.08) and increased 5-year mortality (RR=2.12) . Another study encompassing 13,890 solid tumor patients confirmed that higher AGR values were associated with better OS, CSS, DFS, and DMFS .
Specific Cancers
Prostate Cancer
In prostate cancer (PC), the prognostic value of AGR varies with disease stage. While AGR did not show significant predictive value for staging and biochemical progression in non-metastatic PC, it was a significant predictor of progression-free survival (PFS) and cancer-specific survival (CSS) in metastatic PC cases .
Digestive System Cancers
A meta-analysis focusing on digestive system cancers (DSCs) revealed that low AGR was significantly correlated with poor OS (HR=1.94) and DFS (HR=1.49) . This suggests that AGR can be a useful prognostic marker in DSCs.
Renal Cell Carcinoma
In renal cell carcinoma (RCC), low AGR was associated with worse OS (HR=1.82) and PFS (HR=2.44). Additionally, low AGR correlated with advanced disease stages and other adverse clinicopathological features .
Colorectal Cancer
For colorectal cancer (CRC), low AGR was significantly linked to poor OS (HR=2.58) and DFS/PFS (HR=2.11), making it a reliable prognostic marker for CRC .
Gastric Cancer
In gastric cancer (GC), low AGR was associated with worse OS (HR=1.531) and DFS/PFS (HR=2.008), reinforcing its role as a prognostic indicator .
Lymph Node Metastasis
Low AGR has also been linked to an increased risk of lymph node metastasis (LNM) in various cancers, with a significant increase in risk observed in patients with low AGR compared to those with high AGR (HR=2.24) .
AGR in Inflammatory Diseases
Rheumatoid Arthritis
AGR has been identified as a novel inflammatory marker in rheumatoid arthritis (RA). Studies have shown that AGR is lower in RA patients compared to healthy controls and decreases with increasing disease activity. AGR was found to be inversely associated with the Disease Activity Score of 28 joints-ESR (DAS28-ESR), suggesting its potential as a marker for monitoring RA activity .
Microscopic Polyangiitis
In microscopic polyangiitis (MPA), a low AGR at diagnosis was inversely associated with all-cause mortality during follow-up, indicating its prognostic value in this condition as well .
Conclusion
The albumin-to-globulin ratio (AGR) is a valuable prognostic marker across various diseases, particularly cancers and inflammatory conditions. Low AGR is consistently associated with poor survival outcomes and increased disease progression. Its utility as a cost-effective and reliable prognostic tool makes it a significant parameter in clinical practice. Further research with larger sample sizes and prospective studies is needed to validate these findings and expand the clinical applications of AGR.
Sources and full results
Most relevant research papers on this topic